关注
Alina Allen
Alina Allen
未知所在单位机构
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies
S Singh, AM Allen, Z Wang, LJ Prokop, MH Murad, R Loomba
Clinical gastroenterology and hepatology 13 (4), 643-654. e9, 2015
17732015
Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: a 20 year‐community study
AM Allen, TM Therneau, JJ Larson, A Coward, VK Somers, PS Kamath
Hepatology 67 (5), 1726-1736, 2018
3412018
Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis
RA Bhanji, P Narayanan, AM Allen, H Malhi, KD Watt
Hepatology 66 (6), 2055-2065, 2017
2452017
NASH in lean individuals
R Younes, E Bugianesi
Seminars in liver disease 39 (01), 086-095, 2019
2412019
The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity–a longitudinal cohort study
AM Allen, SB Hicks, KC Mara, JJ Larson, TM Therneau
Journal of hepatology 71 (6), 1229-1236, 2019
2372019
Refinement of K-stiffness method for geosynthetic-reinforced soil walls
RJ Bathurst, Y Miyata, A Nernheim, AM Allen
Geosynthetics International 15 (4), 269-295, 2008
2222008
The role of mucus in the protection of the gastroduodenal mucosa
A Allen, DA Hutton, AJ Leonard, JP Pearson, LA Sellers
Scandinavian Journal of Gastroenterology 21 (sup125), 71-78, 1986
2111986
Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: a systematic review and network meta‐analysis
S Singh, R Khera, AM Allen, MH Murad, R Loomba
Hepatology 62 (5), 1417-1432, 2015
1842015
Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease
JD Yang, F Ahmed, KC Mara, BD Addissie, AM Allen, GJ Gores, ...
Hepatology 71 (3), 907-916, 2020
1822020
Chronic kidney disease and associated mortality after liver transplantation–a time-dependent analysis using measured glomerular filtration rate
AM Allen, WR Kim, TM Therneau, JJ Larson, JK Heimbach, AD Rule
Journal of hepatology 61 (2), 286-292, 2014
1802014
Time trends in the health care burden and mortality of acute on chronic liver failure in the United States
AM Allen, WR Kim, JP Moriarty, ND Shah, JJ Larson, PS Kamath
Hepatology 64 (6), 2165-2172, 2016
1622016
Population screening for liver fibrosis: toward early diagnosis and intervention for chronic liver diseases
P Ginès, L Castera, F Lammert, I Graupera, M Serra‐Burriel, AM Allen, ...
Hepatology 75 (1), 219-228, 2022
1612022
Healthcare cost and utilization in nonalcoholic fatty liver disease: real‐world data from a large US claims database
AM Allen, HK Van Houten, LR Sangaralingham, JA Talwalkar, RG McCoy
Hepatology 68 (6), 2230-2238, 2018
1552018
Hepatocellular carcinoma is the most common indication for liver transplantation and placement on the waitlist in the United States
JD Yang, JJ Larson, KD Watt, AM Allen, RH Wiesner, GJ Gores, ...
Clinical Gastroenterology and Hepatology 15 (5), 767-775. e3, 2017
1502017
Administrative coding in electronic health care record‐based research of NAFLD: an expert panel consensus statement
H Hagström, LA Adams, AM Allen, CD Byrne, Y Chang, H Grønbæk, ...
Hepatology 74 (1), 474-482, 2021
1272021
Reduced access to liver transplantation in women: role of height, MELD exception scores, and renal function underestimation
AM Allen, JK Heimbach, JJ Larson, KC Mara, WR Kim, PS Kamath, ...
Transplantation 102 (10), 1710-1716, 2018
1242018
The epidemiology of liver diseases unique to pregnancy in a US community: a population-based study
AM Allen, WR Kim, JJ Larson, JK Rosedahl, BP Yawn, K McKeon, JE Hay
Clinical Gastroenterology and Hepatology 14 (2), 287-294. e2, 2016
1082016
Challenges and opportunities in NASH drug development
SA Harrison, AM Allen, J Dubourg, M Noureddin, N Alkhouri
Nature medicine 29 (3), 562-573, 2023
1072023
The role of three‐dimensional magnetic resonance elastography in the diagnosis of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery
AM Allen, VH Shah, TM Therneau, SK Venkatesh, T Mounajjed, JJ Larson, ...
Hepatology 71 (2), 510-521, 2020
952020
Recurrent or de novo allograft steatosis and long-term outcomes after liver transplantation
P Narayanan, K Mara, M Izzy, R Dierkhising, J Heimbach, AM Allen, ...
Transplantation 103 (1), e14-e21, 2019
942019
系统目前无法执行此操作,请稍后再试。
文章 1–20